当前位置：
X-MOL 学术
›
Kidney Int.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders
Kidney International ( IF 14.8 ) Pub Date : 2022-07-20 , DOI: 10.1016/j.kint.2022.07.008 Hannah Kaminski 1 , Mickael Gigan 2 , Agathe Vermorel 1 , Manon Charrier 1 , Laura Guirle 2 , Frederic Jambon 1 , Arthur Lacapère 1 , Coline Ménard 1 , Karine Moreau 1 , Martine Neau-Cransac 1 , Marine Novion 1 , Frederique Pribat 2 , Benjamin Taton 1 , Sébastien Borde 3 , Laure Burguet 4 , Charlie Martinez 5 , Magali Jasiek 6 , Pauline D'Halluin 7 , Marie-Edith Lafon 8 , Pierre Merville 1 , Lionel Couzi 1
Kidney International ( IF 14.8 ) Pub Date : 2022-07-20 , DOI: 10.1016/j.kint.2022.07.008 Hannah Kaminski 1 , Mickael Gigan 2 , Agathe Vermorel 1 , Manon Charrier 1 , Laura Guirle 2 , Frederic Jambon 1 , Arthur Lacapère 1 , Coline Ménard 1 , Karine Moreau 1 , Martine Neau-Cransac 1 , Marine Novion 1 , Frederique Pribat 2 , Benjamin Taton 1 , Sébastien Borde 3 , Laure Burguet 4 , Charlie Martinez 5 , Magali Jasiek 6 , Pauline D'Halluin 7 , Marie-Edith Lafon 8 , Pierre Merville 1 , Lionel Couzi 1
Affiliation
Abstract not available
中文翻译：
在肾移植接受者无反应者或低疫苗反应者中，通过 tixagevimab–cilgavimab 暴露前预防可降低 COVID-19 发病率
摘要不可用
更新日期：2022-07-20
中文翻译：
在肾移植接受者无反应者或低疫苗反应者中，通过 tixagevimab–cilgavimab 暴露前预防可降低 COVID-19 发病率
摘要不可用
京公网安备 11010802027423号